Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Development of a duplex real-time RT-qPCR assay to monitor genome replication, gene expression and gene insert stability during in vivo replication of a prototype live attenuated canine distemper virus vector encoding SIV gag.

Coleman JW, Wright KJ, Wallace OL, Sharma P, Arendt H, Martinez J, DeStefano J, Zamb TP, Zhang X, Parks CL.

J Virol Methods. 2015 Mar;213:26-37. doi: 10.1016/j.jviromet.2014.11.015. Epub 2014 Dec 5.

PMID:
25486083
2.

Neurovirulence and immunogenicity of attenuated recombinant vesicular stomatitis viruses in nonhuman primates.

Clarke DK, Nasar F, Chong S, Johnson JE, Coleman JW, Lee M, Witko SE, Kotash CS, Abdullah R, Megati S, Luckay A, Nowak B, Lackner A, Price RE, Little P, Kalyan N, Randolf V, Javadian A, Zamb TJ, Parks CL, Egan MA, Eldridge J, Hendry M, Udem SA.

J Virol. 2014 Jun;88(12):6690-701. doi: 10.1128/JVI.03441-13. Epub 2014 Apr 2.

3.

The stem of vesicular stomatitis virus G can be replaced with the HIV-1 Env membrane-proximal external region without loss of G function or membrane-proximal external region antigenic properties.

Lorenz IC, Nguyen HT, Kemelman M, Lindsay RW, Yuan M, Wright KJ, Arendt H, Back JW, DeStefano J, Hoffenberg S, Morrow G, Jurgens CK, Phogat SK, Zamb TJ, Parks CL.

AIDS Res Hum Retroviruses. 2014 Nov;30(11):1130-44. doi: 10.1089/AID.2013.0206. Epub 2014 Apr 9.

4.

Membrane-bound SIV envelope trimers are immunogenic in ferrets after intranasal vaccination with a replication-competent canine distemper virus vector.

Zhang X, Wallace O, Wright KJ, Backer M, Coleman JW, Koehnke R, Frenk E, Domi A, Chiuchiolo MJ, DeStefano J, Narpala S, Powell R, Morrow G, Boggiano C, Zamb TJ, Richter King C, Parks CL.

Virology. 2013 Nov;446(1-2):25-36. doi: 10.1016/j.virol.2013.07.012. Epub 2013 Aug 9. Erratum in: Virology. 2014 Feb;450-451:371.

5.

Enhanced control of pathogenic Simian immunodeficiency virus SIVmac239 replication in macaques immunized with an interleukin-12 plasmid and a DNA prime-viral vector boost vaccine regimen.

Winstone N, Wilson AJ, Morrow G, Boggiano C, Chiuchiolo MJ, Lopez M, Kemelman M, Ginsberg AA, Mullen K, Coleman JW, Wu CD, Narpala S, Ouellette I, Dean HJ, Lin F, Sardesai NY, Cassamasa H, McBride D, Felber BK, Pavlakis GN, Schultz A, Hudgens MG, King CR, Zamb TJ, Parks CL, McDermott AB.

J Virol. 2011 Sep;85(18):9578-87. doi: 10.1128/JVI.05060-11. Epub 2011 Jul 6.

6.

Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target.

Walker LM, Phogat SK, Chan-Hui PY, Wagner D, Phung P, Goss JL, Wrin T, Simek MD, Fling S, Mitcham JL, Lehrman JK, Priddy FH, Olsen OA, Frey SM, Hammond PW; Protocol G Principal Investigators, Kaminsky S, Zamb T, Moyle M, Koff WC, Poignard P, Burton DR.

Science. 2009 Oct 9;326(5950):285-9. doi: 10.1126/science.1178746. Epub 2009 Sep 3.

7.

Phenotypic properties resulting from directed gene segment reassortment between wild-type A/Sydney/5/97 influenza virus and the live attenuated vaccine strain.

Parks CL, Latham T, Cahill A, O'neill RE, Passarotti CJ, Buonagurio DA, Bechert TM, D'Arco GA, Neumann G, Destefano J, Arendt HE, Obregon J, Shutyak L, Hamm S, Sidhu MS, Zamb TJ, Udem SA.

Virology. 2007 Oct 25;367(2):275-87. Epub 2007 Jun 28. Erratum in: Virology. 2008 May 10;374(2):535-9.

8.

Quantitative multiplex assay for simultaneous detection of the Indiana serotype of vesicular stomatitis virus and HIV gag.

Coleman JW, Ogin-Wilson E, Johnson JE, Nasar F, Zamb TP, Clarke DK, Hendry RM, Udem SA.

J Virol Methods. 2007 Jul;143(1):55-64. Epub 2007 Mar 26.

PMID:
17382412
9.

Genetic stability of live, cold-adapted influenza virus components of the FluMist/CAIV-T vaccine throughout the manufacturing process.

Buonagurio DA, Bechert TM, Yang CF, Shutyak L, D'Arco GA, Kazachkov Y, Wang HP, Rojas EA, O'Neill RE, Spaete RR, Coelingh KL, Zamb TJ, Sidhu MS, Udem SA.

Vaccine. 2006 Mar 15;24(12):2151-60. Epub 2005 Nov 21.

PMID:
16413951
10.

Genetic and phenotypic stability of cold-adapted influenza viruses in a trivalent vaccine administered to children in a day care setting.

Buonagurio DA, O'Neill RE, Shutyak L, D'Arco GA, Bechert TM, Kazachkov Y, Wang HP, DeStefano J, Coelingh KL, August M, Parks CL, Zamb TJ, Sidhu MS, Udem SA.

Virology. 2006 Apr 10;347(2):296-306. Epub 2006 Jan 18.

11.

HIV vaccine design: insights from live attenuated SIV vaccines.

Koff WC, Johnson PR, Watkins DI, Burton DR, Lifson JD, Hasenkrug KJ, McDermott AB, Schultz A, Zamb TJ, Boyle R, Desrosiers RC.

Nat Immunol. 2006 Jan;7(1):19-23. Review.

PMID:
16357854
12.

Herpes simplex virus type 2 UL24 gene is a virulence determinant in murine and guinea pig disease models.

Blakeney S, Kowalski J, Tummolo D, DeStefano J, Cooper D, Guo M, Gangolli S, Long D, Zamb T, Natuk RJ, Visalli RJ.

J Virol. 2005 Aug;79(16):10498-506.

13.

Synthetic luteinizing hormone releasing hormone (LHRH) vaccine for effective androgen deprivation and its application to prostate cancer immunotherapy.

Finstad CL, Wang CY, Kowalski J, Zhang M, Li ML, Li XM, Xia WG, Bosland MC, Murthy KK, Walfield AM, Koff WC, Zamb TJ.

Vaccine. 2004 Mar 12;22(9-10):1300-13.

PMID:
15003660
14.

Transfection-independent production of alphavirus replicon particles based on poxvirus expression vectors.

Vasilakis N, Falvey D, Gangolli SS, Coleman J, Kowalski J, Udem SA, Zamb TJ, Kovacs GR.

Nat Biotechnol. 2003 Aug;21(8):932-5. Epub 2003 Jul 6.

PMID:
12845329
15.

A method of alphavirus replicon particle titration based on expression of functional replicase/transcriptase.

Gangolli SS, Vasilakis N, Kovacs GR, Zamb TJ, Kowalski J.

J Virol Methods. 2003 May;109(2):133-8.

PMID:
12711055
16.

A modified cholera holotoxin CT-E29H enhances systemic and mucosal immune responses to recombinant Norwalk virus-virus like particle vaccine.

Periwal SB, Kourie KR, Ramachandaran N, Blakeney SJ, DeBruin S, Zhu D, Zamb TJ, Smith L, Udem S, Eldridge JH, Shroff KE, Reilly PA.

Vaccine. 2003 Jan 17;21(5-6):376-85.

PMID:
12531635
17.

Crystal structure of the oligomerization domain of NSP4 from rotavirus reveals a core metal-binding site.

Bowman GD, Nodelman IM, Levy O, Lin SL, Tian P, Zamb TJ, Udem SA, Venkataraghavan B, Schutt CE.

J Mol Biol. 2000 Dec 15;304(5):861-71.

PMID:
11124032
18.

The authentic sequence of rotavirus SA11 nonstructural protein NSP4.

Tian P, Ottaiano A, Reilly PA, Udem S, Zamb T.

Virus Res. 2000 Feb;66(2):117-22.

PMID:
10725544
19.

Controlled release microparticles as a single dose diphtheria toxoid vaccine: immunogenicity in small animal models.

Singh M, Li XM, Wang H, McGee JP, Zamb T, Koff W, Wang CY, O'Hagan DT.

Vaccine. 1998 Feb;16(4):346-52.

PMID:
9607054
20.

Biodegradable microparticles with an entrapped branched octameric peptide as a controlled-release HIV-1 vaccine.

Singh M, McGee JP, Li XM, Koff W, Zamb T, Wang CY, O'Hagan DT.

J Pharm Sci. 1997 Nov;86(11):1229-33.

PMID:
9383731
21.

CTL induction using synthetic peptides delivered in emulsions--critical role of the formulation procedure.

Singh M, Hioe C, Qiu H, Li XM, Wang CY, Koff W, Zamb T, Nixon DF.

Vaccine. 1997 Nov;15(16):1773-8.

PMID:
9364682
22.

Immunogenicity and protection in small-animal models with controlled-release tetanus toxoid microparticles as a single-dose vaccine.

Singh M, Li XM, Wang H, McGee JP, Zamb T, Koff W, Wang CY, O'Hagan DT.

Infect Immun. 1997 May;65(5):1716-21.

23.

Controlled release microparticles as a single dose hepatitis B vaccine: evaluation of immunogenicity in mice.

Singh M, Li XM, McGee JP, Zamb T, Koff W, Wang CY, O'Hagan DT.

Vaccine. 1997 Apr;15(5):475-81.

PMID:
9160514
24.

Synthetic peptides entrapped in microparticles can elicit cytotoxic T cell activity.

Nixon DF, Hioe C, Chen PD, Bian Z, Kuebler P, Li ML, Qiu H, Li XM, Singh M, Richardson J, McGee P, Zamb T, Koff W, Wang CY, O'Hagan D.

Vaccine. 1996 Nov;14(16):1523-30.

PMID:
9014294
25.

Comparison of adjuvant formulations for cytotoxic T cell induction using synthetic peptides.

Hioe CE, Qiu H, Chend PD, Bian Z, Li ML, Li J, Singh M, Kuebler P, McGee P, O'Hagan D, Zamb T, Koff W, Allsopp C, Wang CY, Nixon DF.

Vaccine. 1996 Apr;14(5):412-8.

PMID:
8735553
26.

A subunit gIV vaccine, produced by transfected mammalian cells in culture, induces mucosal immunity against bovine herpesvirus-1 in cattle.

van Drunen Littel-van den Hurk S, Van Donkersgoed J, Kowalski J, van den Hurk JV, Harland R, Babiuk LA, Zamb TJ.

Vaccine. 1994 Nov;12(14):1295-302.

PMID:
7856294
27.

Identification of a putative cellular receptor for bovine herpesvirus 1.

Thaker SR, Stine DL, Zamb TJ, Srikumaran S.

J Gen Virol. 1994 Sep;75 ( Pt 9):2303-9.

PMID:
8077928
28.
29.
30.
31.
33.

Role of N-linked glycans in antigenicity, processing, and cell surface expression of bovine herpesvirus 1 glycoprotein gIV.

Tikoo SK, Parker MD, van den Hurk JV, Kowalski J, Zamb TJ, Babiuk LA.

J Virol. 1993 Feb;67(2):726-33.

34.

Protection of cattle from BHV-1 infection by immunization with recombinant glycoprotein gIV.

van Drunen Littel-van den Hurk S, Parker MD, Massie B, van den Hurk JV, Harland R, Babiuk LA, Zamb TJ.

Vaccine. 1993;11(1):25-35.

PMID:
8381248
35.

Heat-shock promoter-driven synthesis of secreted bovine herpesvirus glycoproteins in transfected cells.

Kowalski J, Gilbert SA, van Drunen-Littel-van den Hurk S, van den Hurk J, Babiuk LA, Zamb TJ.

Vaccine. 1993;11(11):1100-7.

PMID:
8249428
36.

The effect of subunit or modified live bovine herpesvirus-1 vaccines on the efficacy of a recombinant Pasteurella haemolytica vaccine for the prevention of respiratory disease in feedlot calves.

Harland RJ, Potter AA, van Drunen-Littel-van den Hurk S, Van Donkersgoed J, Parker MD, Zamb TJ, Janzen ED.

Can Vet J. 1992 Nov;33(11):734-41.

37.

Synthesis and processing of the haemagglutinin-esterase glycoprotein of bovine coronavirus encoded in the E3 region of adenovirus.

Yoo D, Graham FL, Prevec L, Parker MD, Benkö M, Zamb T, Babiuk LA.

J Gen Virol. 1992 Oct;73 ( Pt 10):2591-600.

PMID:
1402802
38.

Structural, functional, and immunological characterization of bovine herpesvirus-1 glycoprotein gl expressed by recombinant baculovirus.

van Drunen Littel-van den Hurk S, Parker MD, Fitzpatrick DR, van den Hurk JV, Campos M, Babiuk LA, Zamb T.

Virology. 1992 Sep;190(1):378-92.

PMID:
1326809
40.

Relationship of bovine herpesvirus 1 immediate-early, early, and late gene expression to host cellular gene transcription.

Seal BS, Whetstone CA, Zamb TJ, Bello LJ, Lawrence WC.

Virology. 1992 May;188(1):152-9.

PMID:
1314450
41.

Multiple administration with interleukin-2 potentiates antigen-specific responses to subunit vaccination with bovine herpesvirus-1 glycoprotein IV.

Hughes HP, Campos M, van Drunen Littel-van den Hurk S, Zamb T, Sordillo LM, Godson D, Babiuk LA.

Vaccine. 1992;10(4):226-30.

PMID:
1373261
42.

Immunopotentiation of bovine herpes virus subunit vaccination by interleukin-2.

Hughes HP, Campos M, Godson DL, Van Drunen Littel-Van den Hurk S, McDougall L, Rapin N, Zamb T, Babiuk LA.

Immunology. 1991 Nov;74(3):461-6.

43.
44.
45.

Bovine herpesvirus 1 attachment to permissive cells is mediated by its major glycoproteins gI, gIII, and gIV.

Liang XP, Babiuk LA, van Drunen Littel-van den Hurk S, Fitzpatrick DR, Zamb TJ.

J Virol. 1991 Mar;65(3):1124-32.

46.

Expression of bovine herpesvirus 1 glycoprotein gIV by recombinant baculovirus and analysis of its immunogenic properties.

van Drunen Littel-van den Hurk S, Parker MD, Fitzpatrick DR, Zamb TJ, van den Hurk JV, Campos M, Harland R, Babiuk LA.

J Virol. 1991 Jan;65(1):263-71.

47.
48.

Molecular mimicry: a herpes virus glycoprotein antigenically related to a cell-surface glycoprotein expressed by macrophages, polymorphonuclear leucocytes, and platelets.

Fitzpatrick DR, Snider M, McDougall L, Beskorwayne T, Babiuk LA, Zamb TJ, Bielefeldt Ohmann H.

Immunology. 1990 Aug;70(4):504-12.

49.

Anti-idiotypic antibodies induce neutralizing antibodies to bovine herpesvirus 1.

Srikumaran S, Onisk DV, Borca MV, Nataraj C, Zamb TJ.

Immunology. 1990 Jul;70(3):284-9.

50.

Expression of bovine herpesvirus type 1 glycoprotein gI in transfected bovine cells induces spontaneous cell fusion.

Fitzpatrick DR, Zamb TJ, Babiuk LA.

J Gen Virol. 1990 May;71 ( Pt 5):1215-9.

PMID:
2161053

Supplemental Content

Support Center